Name: UMIN ID:
Unique ID issued by UMIN | UMIN000053217 |
---|---|
Receipt number | R000060735 |
Scientific Title | Cohort study comparing severe incidence in COVID-19 patients at high risk of severe illness between ensitrelvir administration and administration/non-administration of anti-SARS-CoV-2 drugs using large-scale health insurance association data in Japan |
Date of disclosure of the study information | 2023/12/25 |
Last modified on | 2025/06/30 18:17:18 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2023/12/25 17:28:24 | ||
2 | Update | 2024/01/10 18:41:52 | Public title Public title Acronym Acronym Scientific Title Scientific Title Scientific Title:Acronym Scientific Title:Acronym |
|
3 | Update | 2024/01/10 18:42:42 | Narrative objectives1 |
|
4 | Update | 2024/01/10 18:43:24 | Key exclusion criteria |
|
5 | Update | 2025/06/30 17:18:38 | Recruitment status Date of IRB Other related information Other related information |
|
6 | Update | 2025/06/30 17:48:58 | URL releasing protocol URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted |
|
7 | Update | 2025/06/30 18:14:15 | Date of the first journal publication of results Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events |
|
8 | Update | 2025/06/30 18:17:18 | Outcome measures Outcome measures Plan to share IPD Plan to share IPD IPD sharing Plan description IPD sharing Plan description |